A Phase 1 Open-Label, Dose-Escalation Study Evaluating The Safety, Tolerability, And Pharmacokinetics Of Enzalutamide (Previously Mdv3100) Alone Or In Combination With An Aromatase Inhibitor In Women With Advanced Breast Cancer

CANCER RESEARCH(2013)

Cited 4|Views7
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined